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“Gridlock” is a term that has been applied to the state of health policy in Canada and the United States for the past decade and longer. Dr. Forest has 
made a compelling case for five advances in health research 
that will bring about a revolution in health policy (1), and I 
would not challenge any of them, although I would emphasize 
the importance of tackling socio-economic health inequalities, 
which Mackenbach et al. have estimated to have accounted for 
20% of healthcare costs in the European Union in 2004 (2). 
Moreover, the Organization for Economic Cooperation and 
Development (OECD) has reported that income inequality1 
increased more between 2007 and 2010 than it did in the 
previous 12 years, which suggests that this could be a major cost 
driver in the years ahead (3). 
I would like to add, however, that over the past few decades we 
have arrived at two fundamental changes in the way that we 
approach health and healthcare that will also have significant 
implications for health policy.
The first of these is the development of an outcome focus on 
healthcare. Although it had early origins such as Florence 
Nightingale’s efforts to record outcomes during the Crimean 
War in the 1850s, and Ernest Codman’s work on the “end 
results” of medical care in the early 1900s, a focus on outcomes 
has been slow to come about (4,5). 
Like Dr. Forest, I too would pay homage to Donabedian, 
specifically to his 1966 paper in which he set out the structure, 
process and outcome framework for assessing the quality of care 
(6).  To this day, the quality field continues to be preoccupied 
with intermediate outcomes of the processes of care that have 
implications for patient safety. In his 1966 classic, Donabedian 
identified five challenging aspects of using outcomes to measure 
1. Excluding the effects of social welfare programs.
the quality of care:
•	 The chosen outcome might be inappropriate (e.g. using 
survival as a criterion when the outcome might be a 
crippling disability);
•	 The fact that many factors other than medical care 
determine outcomes;
•	 It may take a long time for outcomes to occur;
•	 Medical technology is not fully effective and there is 
uncertainty about success; and
•	 Aside from survival/death other more subjective measures 
such as patient attitudes, satisfaction, and disability/
rehabilitation are more difficult to measure (6).
Although these considerations continue to apply almost 50 
years later, great strides have been made in measuring individual 
and population health status. A key contribution has been the 
development of relatively short indices that capture dimensions 
of physician and emotional health, such as the 36-item Short-
Form Health Survey, and the 15-item Euroqol 5-D, which have 
now been studied in many populations (7,8).  While many of the 
original applications were in health economics, such as studies 
to establish cost-effectiveness measures, they are now being 
rebranded as Patient-Reported Outcome Measures (PROMs). 
Since 2009, the English National Health Service (NHS) has 
mandated the pre- and post-operative collection of PROMs 
data for four procedures including hip and knee replacement, 
varicose vein surgery and groin hernia surgery, and the results 
are regularly reported (9). Research is underway to assess the 
applicability of PROMs to chronic conditions such as chronic 
obstructive pulmonary disease and diabetes (10). 
There has also been considerable research on the application 
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of such indicators for the development of composite measures 
of population health status, that has gained significant traction 
since the 1993 World Development Report, which popularized 
the concept of Disability Adjusted Life Years (11). Stine et al. 
have recently proposed how Health Adjusted Life Expectancy 
can be applied in clinical settings (12).
Where are these developments taking us? I am convinced that 
ultimately health systems will remunerate providers based on 
improvements in outcome and not so much on volumes or 
processes of care. Indeed, Kindig set out an ambitious proposal 
for such an approach in the 1990s, but I have not seen any 
uptake as yet (13). However there has been a huge proliferation 
of “Pay for Performance (P4P)” projects over the past decade 
that are linked to process of care and intermediate outcomes, 
such as blood pressure control, although there is also a large 
critical literature of P4P.
Second, I would contend that we are still in the early phase 
of a Copernican revolution in healthcare in which healthcare 
providers revolve around the patient rather than the reverse 
situation that has been the case since the advent of the modern 
hospital. I would argue that an early milestone of this revolution 
was the 1989 White Paper Working for Patients, issued by 
Prime Minister Margaret Thatcher’s government in the United 
Kingdom (UK). One of its two key objectives was “to give 
patients, wherever they live in the UK, better healthcare and 
greater choice of the services available” (14). Since that time, 
the English NHS has achieved a remarkable transformation, 
particularly in the area of wait times. Working for Patients led 
to the first UK Patient Charter in 1991 that included, among 
10 rights “to be guaranteed hospital admission for treatment 
by a specific date within two years” (15). This was followed 
by a second iteration of the Charter and a series of clinical 
services frameworks, and then in 2004 the government made 
a further commitment that by 2008 no one would wait longer 
than 18 weeks from GP referral to hospital treatment (16). This 
commitment is now embodied in the NHS Constitution (17) 
which also includes the right to be seen by a cancer specialist 
within two weeks when a GP suspects cancer (18). The results 
over time have been striking. In March 1989, just after Working 
for Patients was issued, more than one in four (26.1%) of 
patients waiting for hospital admission was waiting for more 
than one year (19).  As of December 2013 (and reporting data 
that current is a remarkable achievement itself) there were 
109 patients waiting for hospital treatment longer than 1 year, 
representing 0.04% of the total. Since August 2008 with few 
exceptions, more than 90% of patients admitted for treatment 
begin within the 18 weeks guarantee and this exceeds 95% 
among those not requiring admission for treatment (20).
Looking ahead, another aspect of this revolution is the 
recognition that patients have a key role (and responsibility) 
to play in choices and decisions about their health and 
healthcare. The most recent example of this is the Choosing 
Wisely campaign of the American Board of Internal Medicine 
(ABIM) Foundation (21). The origin of this campaign was a 
2010 challenge by Howard Brody to national specialty societies 
to develop “Top 5” lists of services that are both expensive and 
shown by evidence to be of no benefit to a large proportion 
of patients for whom they are commonly ordered (22). The 
influential U.S. publication Consumer Reports is a partner 
in the campaign and is developing materials to help patients 
discuss these services with their physicians. Other countries 
including Canada are planning to implement their own versions 
of Choosing Wisely.
In summary, I think if we continue to advance the study of 
health outcomes and their valuation by patients and if we 
facilitate patient engagement in decisions about their care, this 
will also contribute to answering the questions that Dr. Forest 
enumerates at the conclusion of his paper that focus on resource 
allocation and return on investment.
For me, however, there is an outstanding  and vexing question, 
and that is, have governments succeeded in bending the cost 
curve? According to the OECD per capita health spending fell 
in 11 of 33 member countries between 2009 and 2011 (23). As 
Saltman and Cahn have pointed out, this climate will pose major 
challenges in healthcare governance and financing (24). On the 
horizon, the field of regenerative medicine aims to replace or 
repair organs and tissues through new therapies composed 
of living cells, although this is likely to take some time (25). 
Ultimately, I think the question we have to answer is; will cost-




The author declares that he has no competing interests.
Author’s contribution
OA is the single author of the manuscript.
References
1. Forest PG. A new synthesis. Int J Health Policy Manag 2014; 2: 
55–7.
2. Mackenbach JP, Meerding WJ, Kunst AE. Economic costs of 
health inequalities in the European Union. J Epidemiol Community 
Health 2011; 65: 412–9.
3. Organization for Economic Cooperation and Development 
(OECD). Crisis squeezes income and puts pressure on inequality 
and poverty [internet]. 2013 [cited 2014 March 15]. Available from: 
http://www.oecd.org/els/soc/OECD2013-Inequality-and-Poverty-
8p.pdf
4. Neuhauser D. Florence Nightingale gets no respect: as a statistician 
that is. Qual Saf Health Care 2003; 12: 317.
5. Neuhauser D. Ernest Amory Codman, M.D., and end results in 
medical care. Int J Technol Assess Health Care 1990; 6: 307–25.
6. Donabedian A. Evaluating the quality of medical care. Milbank 
Mem Fund Q 1966; 44: 166–203.
7. Ware JE, Sherbourne CD. The MOS 36-item short-form health 
survey (SF-36): I. Conceptual framework and item selection. Med 
Care 1992; 30: 473–83.
8. Kind P, Brooks R, Rabin R. EQ-5D concepts and methods: a 
developmental history. Dordrecht: Springer; 2005.
9. Health & Social Care Information Centre. Provisional monthly patient 
reported outcome measures (PROMs) in England - April 2013 to 
August 2014 [internet]. 2013 [cited 2014 March 12]. Available from: 
http://www.hscic.gov.uk/catalogue/PUB13246
10. Peters M, Crocker H, Jenkinson C, Doll H, Fitzpatrick R. The 
routine collection of patient-reported outcome measures (PROMs) 
for long-term conditions in primary care: a cohort survey. BMJ 
Open 2014; 4: e003968. 
11. World Development Bank. World development report 1993. 
Investing in health. New York: Oxford University Press; 1993.
12. Stine N, Stevens D, Braithwhite RS, Gourevitch MN, Wilson RM. 
HALE and hearty: toward more meaningful health measurement in 
the clinical setting. Healthcare 2013; 1: 86–90.
13. Kindig DA. Purchasing population health: paying for results. Ann 
Arbor, Michigan: University of Michigan Press; 1997.
Adams
International Journal of Health Policy and Management, 2014, 2(3), 145–147 147
14. Secretaries of State for Health, Wales, Northern Ireland and 
Scotland. Working for Patients. London: Her Majesty’s Stationery 
Office; 1989.
15. Warden J. Patients first. BMJ 1991; 303: 1153.
16. Department of Health. The NHS improvement plan: putting people 
at the heart of public services. London: Her Majesty’s Stationery 
Office; 2004.
17. National Health Service (NHS) The NHS Constitution [internet]. 
2013 [cited 2014 March 12]. Available from: https://www.gov.
uk/government/uploads/system/uploads/attachment_data/
file/170656/NHS_Constitution.pdf
18. National Health Service (NHS). The handbook to the NHS Consti-
tution [internet]. 2013 [cited 2014 March 12]. Available from: http://
www.nhs.uk/choiceintheNHS/Rightsandpledges/NHSConstitution/
Documents/2013/handbook-to-the-nhs-constitution.pdf
19. Morgan B, Wright K. Hospital waiting lists and waiting times. 
Research paper 99/60. London: House of Commons Library; 1999.
20. National Health Service (NHS). Referral to treatment (RTT) waiting 
times, England [internet]. April 2007 to December 2013 [cited 2014 
March 12]. Available from: http://www.england.nhs.uk/statistics/
statistical-work-areas/rtt-waiting-times/rtt-data-2013-14/
21. See www.choosingwisely.org
22. Brody H. Medicine’s ethical responsibility for health care reform-
the Top Five list. N Engl J Med 2010; 362: 283–5.
23. Organization for Economic Cooperation and Development. Health 
at a glance 2013: OECD indicators. Paris: OECD Publishing; 2013.
24. Saltman RB, Cahn Z. Restructuring health systems for an era of 
prolonged austerity: an essay by Richard B Saltman and Zachary 
Cahn. BMJ 2013; 346: f3972. 
25. Polak J. Regenerative medicine. Opportunities and challenges: 
a brief overview. Journal of the Royal Society Interface 2010; 7: 
S777–81.
